- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Search trials
Studi clinici sponsorizzati da Richard H. Lee
Totale 556 risultati
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletatoCancro alla prostataStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Terminato
-
H. Lee Moffitt Cancer Center and Research InstituteKyowa Hakko Kirin Pharma, Inc.ReclutamentoMicosi fungoideStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseReclutamentoTumore del pancreasStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseReclutamentoCarcinoma uroteliale | Carcinoma uroteliale della vescica non invasivoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH)ReclutamentoComportamento sanitarioStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesAttivo, non reclutanteCarcinoma uroteliale metastaticoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; MultiVir, Inc.TerminatoCancro polmonare a piccole cellule | Cancro ai polmoni | Carcinoma polmonare a piccole cellule recidivatoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Celgene CorporationCompletato
-
Georgetown UniversityWayne State University; H. Lee Moffitt Cancer Center and Research InstituteCompletatoFemmina di cancro al senoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletatoCancro ai polmoni | Carcinoma polmonare non a piccole cellule (NSCLC)Stati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH)Completato
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer; National Comprehensive Cancer NetworkCompletato
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseTerminatoCancro ovaricoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstitutePatient-Centered Outcomes Research InstituteCompletato
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseCompletato
-
H. Lee Moffitt Cancer Center and Research InstituteNational Comprehensive Cancer Network; CephalonTerminatoMetastasi cerebraliStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); UpjohnCompletatoLinfoma | LeucemiaStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH)ReclutamentoCancro orofaringeo | Carcinoma correlato all'HPVStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseReclutamentoCancro al seno triplo negativo | Cancro al seno HER2-positivo | Malattia leptomeningeaStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteCancer and Aging Research GroupReclutamentoLinfoma | Leucemia | MielomaStati Uniti
-
Memgen, Inc.H. Lee Moffitt Cancer Center and Research Institute; Duke Cancer InstituteReclutamentoMelanoma | Cancro testa e collo | Tumore del pancreas | Tumore solido | Carcinoma polmonare non a piccole cellule | Cancro metastatico | Cancro al seno triplo negativo | Cancro avanzato | Carcinoma a cellule di Merkel | Carcinoma cutaneo a cellule squamoseStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Jazz PharmaceuticalsTerminatoCancro polmonare a piccole cellule | Carcinoma polmonare a piccole cellule recidivato | Carcinoma polmonare a piccole cellule ricorrenteStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseAttivo, non reclutanteVaccino a cellule dendritiche diretto HER2 durante la terapia neoadiuvante del cancro al seno HER2 +Cancro al seno | Cancro al seno, maschio | Cancro al seno HER2-positivo | Cancro al seno invasivo | Cancro al seno in stadio II | Femmina di cancro al seno | Carcinoma mammario HER2 positivo | Cancro al seno in stadio IIIStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; SmithKline BeechamCompletatoMieloma multiplo | Neoplasia plasmacellulareStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH)CompletatoCancro alla prostataStati Uniti, Porto Rico
-
University of California, San FranciscoH. Lee Moffitt Cancer Center and Research InstituteTerminato
-
H. Lee Moffitt Cancer Center and Research InstituteJohns Hopkins All Children's HospitalRitiratoNeoplasie, tessuto nervoso | Neuroblastoma
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); AstraZenecaTerminatoCancro ai polmoniStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseReclutamentoTumore del pancreasStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseAttivo, non reclutanteCancro al seno, maschio | Cancro al seno HER2-positivo | Cancro al seno Stadio I | Stadio del cancro al seno II | Femmina di cancro al seno | Stadio del cancro al seno III | Malattia residua | Carcinoma mammario HER2 positivoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH)Completato
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); GlaxoSmithKlineCompletato
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); PfizerCompletatoNeoplasie, avanzatoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute of Nursing Research (NINR)Attivo, non reclutanteLeucemia mieloide acuta | LMA, adultoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteBTG International Inc.; Biocompatibles UK LtdNon più disponibileNeoplasie del fegato | Cancro al fegato | Carcinoma epatocellulareStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Janssen PharmaceuticalsTerminatoCancro alla prostataStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Chiron CorporationCompletatoCancro ai reniStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Parke-DavisCompletato
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Aventis PharmaceuticalsCompletato
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron Pharmaceuticals; Genzyme, a Sanofi CompanyReclutamentoMelanoma uveale metastaticoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA)Reclutamento
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Iovance Biotherapeutics, Inc.Attivo, non reclutanteMelanoma metastaticoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteAbramson Cancer Center at Penn MedicineCompletatoCancro al senoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteSusan G. Komen Breast Cancer FoundationCompletato
-
H. Lee Moffitt Cancer Center and Research InstituteEli Lilly and Company; Genentech, Inc.TerminatoCarcinoma polmonare non a piccole celluleStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteEli Lilly and Company; Aventis PharmaceuticalsCompletatoCarcinoma, polmone non a piccole celluleStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); SmithKline BeechamCompletato
-
H. Lee Moffitt Cancer Center and Research InstituteEMD Serono Research & Development Institute, Inc.Non ancora reclutamentoGlioma ricorrente di alto gradoStati Uniti
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLC; Prometheus LaboratoriesAttivo, non reclutante